您的位置: 首页 > 农业专利 > 详情页

Pharmaceutical compositions to reduce complications of ocular steroid
专利权人:
TLC Biopharmaceuticals;TLC Biopharmaceuticals, Inc;Taiwan Liposome Company, Ltd; Inc
发明人:
Hong, Keelung,Guo, Luke S.S.,Tseng, Yun-Long,Shih, Sheue-Fang,Chang, Po-Chun,Tsai, Chih-Chiang,Lin, Hong-Hui
申请号:
AU2013216861
公开号:
AU2013216861B2
申请日:
2013.02.08
申请国别(地区):
AU
年份:
2017
代理人:
摘要:
The present invention relates to pharmaceutical compositions comprising a combination of a lipid cake mixture comprising one or more phospholipids, with or without cholesterol, and a steroid solution comprising an ocular steroid, derivative thereof, a pharmaceutically acceptable salt thereof or a prodrug thereof, wherein the total amount of the phospholipid in the said composition is about 0.1 umol to less than about 2.5umol per 50ul of pharmaceutical composition and the side effects of the ocular steroid are reduced. The pharmaceutical composition is preferably administered by ocular route to treat ophthalmic diseases.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充